journal
https://read.qxmd.com/read/32958540/challenges-in-the-management-of-pregnant-patients-with-cardiovascular-diseases
#1
LETTER
Ahmet Güner, Macit Kalçık, Ezgi Gültekin Güner, Mehmet Ertürk, Mehmet Özkan
No abstract text is available yet for this article.
September 21, 2020: Heart
https://read.qxmd.com/read/32938773/incidence-predictors-and-prognostic-impact-of-recurrent-acute-myocardial-infarction-in-china
#2
Jiali Song, Karthik Murugiah, Shuang Hu, Yan Gao, Xi Li, Harlan M Krumholz, Xin Zheng
BACKGROUND: Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction (AMI) after initial AMI remain poorly understood. Data on recurrent AMI in China is unknown. METHODS: Using the China Patient-centred Evaluative Assessment of Cardiac Events (PEACE)-Prospective AMI Study, we studied 3387 patients admitted to 53 hospitals for AMI and discharged alive. The association of recurrent AMI with 1-year mortality was evaluated using time-dependent Cox regression...
September 16, 2020: Heart
https://read.qxmd.com/read/32938772/premature-permanent-discontinuation-of-apixaban-or-warfarin-in-patients-with-atrial-fibrillation
#3
Anthony P Carnicelli, Sana M Al-Khatib, Denis Xavier, Frederik Dalgaard, Peter D Merrill, Daniel M Wojdyla, Basil S Lewis, Michael Hanna, John H Alexander, Renato D Lopes, Lars Wallentin, Christopher B Granger
AIMS: The ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial randomised patients with atrial fibrillation at risk of stroke to apixaban or warfarin. We sought to describe patients from ARISTOTLE who prematurely permanently discontinued study drug. METHODS/RESULTS: We performed a posthoc analysis of patients from ARISTOTLE who prematurely permanently discontinued study drug during the study or follow-up period...
September 16, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32933999/familial-hypercholesterolaemia-history-diagnosis-screening-management-and-challenges
#4
Erik Berg Schmidt, Berit Storgaard Hedegaard, Kjetil Retterstøl
No abstract text is available yet for this article.
September 15, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32928893/improving-the-imaging-diagnosis-of-mitral-annular-disjunction
#5
EDITORIAL
Kristina Haugaa
No abstract text is available yet for this article.
September 14, 2020: Heart
https://read.qxmd.com/read/32917733/the-quest-for-an-aortic-stenosis-cure
#6
EDITORIAL
Rong Bing, Marc Richard Dweck
No abstract text is available yet for this article.
September 11, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32917732/dipeptidyl-peptidase-4-inhibition-to-prevent-progression-of-calcific-aortic-stenosis
#7
Sahmin Lee, Seung-Ah Lee, Bongkun Choi, Ye-Jee Kim, Soo Jin Oh, Hong-Mi Choi, Eun Kyoung Kim, Dae-Hee Kim, Goo-Yeong Cho, Jong-Min Song, Seung Woo Park, Duk-Hyun Kang, Jae-Kwan Song
OBJECTIVE: To evaluate whether the use of dipeptidyl peptidase-4 (DPP-4) inhibitors and their cardiac tissue distribution profile and anticalcification abilities are associated with risk of aortic stenosis (AS) progression. METHODS: Out of the five different classes of DPP-4 inhibitors, two had relatively favourable heart to plasma concentration ratios and anticalcification ability in murine and in vitro experiments and were thus categorised as 'favourable'. We reviewed the medical records of 212 patients (72±8 years, 111 men) with diabetes and mild-to-moderate AS who underwent echocardiographic follow-up and classified them into those who received favourable DPP-4 inhibitors (n=28, 13%), unfavourable DPP-4 inhibitors (n=69, 33%) and those who did not receive DPP-4 inhibitors (n=115, 54%)...
September 11, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32907826/instantaneous-pressure-flow-relationships-in-aortic-stenosis
#8
LETTER
Catherine M Otto, Javier Bermejo
No abstract text is available yet for this article.
September 9, 2020: Heart
https://read.qxmd.com/read/32907825/reply-to-instantaneous-pressure-flow-relationships-in-aortic-stenosis
#9
LETTER
Rong Bing, Haotian Gu, David E Newby, Phil Chowienczyk, Marc Richard Dweck
No abstract text is available yet for this article.
September 9, 2020: Heart
https://read.qxmd.com/read/32907824/tailoring-anticoagulant-treatment-of-patients-with-atrial-fibrillation-using-a-novel-bleeding-risk-score
#10
Gordon Chu, Luca Valerio, Sake J van der Wall, Stefano Barco, Stavros Konstantinides, Menno V Huisman, Frederikus A Klok
OBJECTIVES: Current international guidelines advocate the application of bleeding risk scores only to identify modifiable risk factors, but not to withhold treatment in patients at high risk of bleeding. VTE-BLEED (ActiVe cancer, male with uncontrolled hyperTension, anaEmia, history of BLeeding, agE and rEnal Dysfunction) is a simple bleeding risk score that predicts major bleeding (MB) in patients with venous thromboembolism, but has never been evaluated in patients with atrial fibrillation (AF)...
September 9, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32895314/right-ventricle-in-heart-failure-with-preserved-ejection-fraction
#11
REVIEW
Felix Berglund, Pamela Piña, César J Herrera
Heart failure with preserved ejection fraction (HFpEF) affects half of all patients with heart failure. While previously neglected, the right ventricle (RV) has sparked interest in recent years as a means for better understanding this condition and as a potential therapeutic target.Right ventricular dysfunction (RVD) is present in 4%-50% of patients with HFpEF. The RV is intimately connected to the pulmonary circulation, and pulmonary hypertension is commonly implicated in the pathophysiology of RVD. The development of RVD in HFpEF may also be driven by comorbidities, such as chronic obstructive pulmonary disease, obesity, obstructive sleep apnoea and atrial fibrillation...
September 7, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32887738/neurocognitive-and-psychosocial-outcomes-in-adult-congenital-heart-disease-a-lifespan-approach
#12
Adrienne H Kovacs, David C Bellinger
No abstract text is available yet for this article.
September 4, 2020: Heart
https://read.qxmd.com/read/32887737/sex-differences-in-prevalence-treatment-and-control-of-cardiovascular-risk-factors-in-england
#13
Ana Catarina Pinho-Gomes, Sanne A E Peters, Blake Thomson, Mark Woodward
OBJECTIVE: To investigate sex differences in prevalence, treatment and control of major cardiovascular risk factors in England. METHODS: Data from the Health Survey for England 2012-2017 on non-institutionalised English adults (aged ≥16 years) were used to investigate sex differences in prevalence, treatment and control of major cardiovascular risk factors: body mass index, smoking, systolic blood pressure and hypertension, diabetes, and cholesterol and dyslipidaemia...
September 4, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32887736/role-of-beta-blockers-following-percutaneous-coronary-intervention-for-acute-coronary-syndrome
#14
Kah Yong Peck, Nick Andrianopoulos, Diem Dinh, Louise Roberts, Stephen J Duffy, Martin Sebastian, David Clark, Angela Brennan, Ernesto Oqueli, Andrew E Ajani, Christopher M Reid, Melanie Freeman, Andrew W Teh
AIMS: There is a paucity of evidence supporting routine beta blocker (BB) use in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). The aim of this study was to evaluate BB use post PCI and its association with mortality. Furthermore, the study aimed to evaluate the association between BB and mortality in the subgroups of patients with left ventricular ejection fraction (LVEF) <35%, LVEF 35%-50% and LVEF >50%. METHODS: Using a large PCI registry, data from patients with ACS between January 2005 and June 2017 who were alive at 30 days were analysed...
September 4, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32878922/what-to-do-when-things-go-wrong
#15
Daniel McKenzie
No abstract text is available yet for this article.
September 2, 2020: Heart
https://read.qxmd.com/read/32878921/frequency-and-prognostic-impact-of-right-ventricular-involvement-in-acute-myocardial-infarction
#16
Thomas Stiermaier, Sören J Backhaus, Jonas Matz, Alexander Koschalka, Johannes Kowallick, Suzanne de Waha-Thiele, Steffen Desch, Matthias Gutberlet, Gerd Hasenfuß, Holger Thiele, Ingo Eitel, Andreas Schuster
OBJECTIVE: Right ventricular (RV) involvement complicating myocardial infarction (MI) is thought to impact prognosis, but potent RV markers for risk stratification are lacking. Therefore, the aim of this trial was to assess the frequency and prognostic implications of concomitant structural and functional RV injury in MI. METHODS: Cardiac magnetic resonance (CMR) was performed in 1235 patients with MI (ST-elevation myocardial infarction: n=795; non-STEMI: n=440) 3 days after reperfusion by primary percutaneous coronary intervention...
September 2, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32878920/optimal-management-of-acute-coronary-syndromes-in-the-era-of-covid-19
#17
Sukhjinder Singh Nijjer, Ricardo Petraco, Sayan Sen
No abstract text is available yet for this article.
September 2, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32868282/interleukin-1-inhibition-with-anakinra-a-valuable-ally-to-reverse-constrictive-pericarditis
#18
EDITORIAL
George Lazaros, Dimitris Tousoulis
No abstract text is available yet for this article.
August 31, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32868281/anakinra-for-constrictive-pericarditis-associated-with-incessant-or-recurrent-pericarditis
#19
Alessandro Andreis, Massimo Imazio, Carla Giustetto, Antonio Brucato, Yehuda Adler, Gaetano Maria De Ferrari
OBJECTIVE: Frequent flares of pericardial inflammation in recurrent or incessant pericarditis with corticosteroid dependence and colchicine resistance may represent a risk factor for constrictive pericarditis (CP). This study was aimed at the identification of CP in these patients, evaluating the efficacy and safety of anakinra, a third-line treatment based on interleukin-1 inhibition, to treat CP and prevent the need for pericardiectomy. METHODS: Consecutive patients with recurrent or incessant pericarditis with corticosteroid dependence and colchicine resistance were included in a prospective cohort study from 2015 to 2018...
August 31, 2020: Heart: Official Journal of the British Cardiac Society
https://read.qxmd.com/read/32868280/impact-of-covid-19-on-percutaneous-coronary-intervention-for-st-elevation-myocardial-infarction
#20
Chun Shing Kwok, Chris P Gale, Tim Kinnaird, Nick Curzen, Peter Ludman, Evan Kontopantelis, Jianhua Wu, Tom Denwood, Nadeem Fazal, John Deanfield, Mark A de Belder, Mamas Mamas
BACKGROUND: The objective of the study was to identify any changes in primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in England by analysing procedural numbers, clinical characteristics and patient outcomes during the COVID-19 pandemic. METHODS: We conducted a retrospective cohort study of patients who underwent PCI in England between January 2017 and April 2020 in the British Cardiovascular Intervention Society-National Institute of Cardiovascular Outcomes Research database...
August 31, 2020: Heart
journal
journal
20116
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"